跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
得每通 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pancreatin Enteric-coated Capsules
Approved
化学药品
Pancreatin Enteric-coated Capsules
Abbott Laboratories GmbH
🇨🇳 National Medical Products Administration
Approval Date
Nov 9, 2022
Approval ID
9ddf00d0bea8d4e0
Company
Abbott Laboratories GmbH
Type
化学药品
Approval Details
Approval Id
9ddf00d0bea8d4e0
Approval Number
国药准字HJ20225003
Generic Name
胰酶肠溶胶囊
Generic Name En
Pancreatin Enteric-coated Capsules
Trade Name
得每通
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.3g(相当于胰脂肪酶20000欧洲药典单位,胰淀粉酶16000欧洲药典单位,胰蛋白酶1200欧洲药典单位)
Reg Date
2022-11-09
Expired Date
2027-01-29
Company Name
Abbott Laboratories GmbH
Production Company Name
Abbott Laboratories GmbH
Company Detail Path
/organization/abbott-laboratories-gmbh
Production Company Detail Path
/organization/abbott-laboratories-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 9, 2022
Approval ID
9ddf00d0bea8d4e0
Type
化学药品
Back to NMPA Approvals